Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third......
US drug transnational Eli Lilly, which thus far was slow on launching its major drugs in India owing to inadequate patent protection, is now gearing up to launch a new drug every year.Eli Lilly &......
Swiss drug major Novartis’ multi-billion-dollar overhaul through deals with two multinational firms -- GlaxoSmithKline and Eli Lilly -- is likely to have an impact on the Indian market, too,......
In another setback to Big Pharma, US drug major Eli Lilly's blockbuster erectile dysfunction drug Cialis (generic name:Tadalafil) has failed to qualify for a product patent in India after the basic......
Eli Lilly and Co (India), Sanofi Aventis and Bristol Myers Squibb India Pvt are among the multinational pharmaceutical companies that are trying to get their products included in the duty exempted......